![Galya Blachman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Galya Blachman
General Counsel at
501 ACQU
Profile
Galya D.
Blachman is currently Chief Legal Officer & Head-Business Development at Enliven Therapeutics, Inc. since 2023.
Legal Advisor at 5AM Venture Management LLC since 2022.
Secretary & General Counsel at 5:01 Acquisition Corp.
since 2020.
General Counsel at Biotech Connection-Bay Area, Inc. since 2018.
Formerly Legal Director at Stemcentrx, Inc. from 2012 to 2017.
Also worked as Head-Legal, Research & Development at AbbVie Stemcentrx LLC.
Education includes a doctorate from the University of Cambridge in 2004, a graduate degree from the University of Oxford in 2009, graduate and undergraduate degrees from the University of Cape Town in 2001 and 2000 respectively, and a graduate degree from BPP Law School in 2006.
Galya Blachman active positions
| Companies | Position | Start |
|---|---|---|
| 501 ACQU | General Counsel | 01/09/2020 |
| ENLIVEN THERAPEUTICS, INC. | General Counsel | 01/07/2023 |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | General Counsel | 01/09/2018 |
Former positions of Galya Blachman
| Companies | Position | End |
|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | General Counsel | 01/01/2017 |
AbbVie Stemcentrx LLC | Corporate Officer/Principal | - |
Training of Galya Blachman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
89
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
BPP Law School
 BPP Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbbVie Stemcentrx LLC | |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Enliven Therapeutics, Inc.
 Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
- Stock Market
- Insiders
- Galya Blachman
